Court of Appeals Sides with Qiagen in HPV Antitrust Case | GenomeWeb

NEW YORK (GenomeWeb News) – The US Court of Appeals for the Federal Circuit has denied an appeal by Third Wave Technologies, a subsidiary of Hologic, to overturn a decision in favor of Qiagen in an antitrust suit brought by Third Wave related to molecular tests for human papillomavirus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."